Evotec SE ADR (EVO) concluded trading on Thursday at a closing price of $3.60, with 0.49 million shares of worth about $1.78 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 24.14% during that period and on April 17, 2025 the price saw a gain of about 10.09%. Currently the company’s common shares owned by public are about 354.61M shares, out of which, 336.66M shares are available for trading.
Stock saw a price change of 17.65% in past 5 days and over the past one month there was a price change of -0.28%. Year-to-date (YTD), EVO shares are showing a performance of -13.46% which decreased to -48.64% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.84 but also hit the highest price of $7.77 during that period. The average intraday trading volume for Evotec SE ADR shares is 72.77K. The stock is currently trading 9.22% above its 20-day simple moving average (SMA20), while that difference is down -4.43% for SMA50 and it goes to -10.53% lower than SMA200.
Evotec SE ADR (NASDAQ: EVO) currently have 354.61M outstanding shares and institutions hold larger chunk of about 1.20% of that.
The stock has a current market capitalization of $1.28B and its 3Y-monthly beta is at 1.70. It has posted earnings per share of -$0.52 in the same period. It has Quick Ratio of 1.99 while making debt-to-equity ratio of 0.49. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for EVO, volatility over the week remained 3.47% while standing at 4.01% over the month.
Analysts are in expectations that Evotec SE ADR (EVO) stock would likely to be making an EPS of 0 in the current quarter, while forecast for next quarter EPS is 0 and it is -0.16 for next year. For the current quarter EPS, analysts have given the company a lowest target 0 which is 0 at the higher side of the target for the same. Stock’s fiscal year EPS is expected to drop by -146.86% while it is estimated to increase by 60.78% in next year.
Stock get a Buy rating from Deutsche Bank on April 12, 2024.
